Cardinal Health Acquiring Viasys | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Cardinal Health Acquiring Viasys

May 14, 2007
by root
| Reprints

Dublin, Ohio-based Cardinal Health plans to acquire Conshohocken, Pa.-based Viasys for approximately $1.5 billion, including the assumption of outstanding debt. Viasys Healthcare Inc. is a global, research-based medical technology company focused on respiratory, neurology and orthopedic products.

According to Cardinal, the acquisition will enable the company to:

· Deliver comprehensive bedside, patient safety offerings to acute-care customers.

· Better serve customers globally.

· Enhance its product and intellectual property portfolio.

· Realize synergies through existing capabilities and platforms.

Under the agreement, Cardinal Health will acquire Viasys in a two-step transaction. In the first step, Cardinal will make a cash tender offer to acquire all outstanding shares of Viasys common stock at $42.75 per share. The second step will consist of a merger in which the holders of the outstanding shares of Viasys common stock that were not purchased in the tender offer will receive the same per share price paid in the tender offer, in cash, without interest.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).